Global Serological Testing Market – Industry Trends and Forecast to 2030

Serological Testing Market Analysis and Size

In 2019, as per the Centers for Diseases Control and Prevention, approximately 34,800 new HIV cases were registered in the U.S. Different serology tests are used to identify antibodies or antigens. Some of the most vital applications for the solutions and products that the market players in the market develop include rotavirus infections, therapeutic drug monitoring, HIV, hepatitis, endotoxins, and other infectious diseases.

Data Bridge Market Research analyses that the serological testing market is expected to reach USD 7.6 billion by 2030, which is USD 4.52 billion in 2022, and is expected to undergo a CAGR of 6.70% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Serological Testing Market Scope and Segmentation

Market Definition

Serology tests are used to identify antibodies or antigens. When the body comes in contact with an antigen, the immune system releases antibodies as a defense mechanism and tries to normalize the antigen. In serological testing, such antigens and antibodies are validated for the diagnosis of a specific disease and condition that further helps doctors give proper medical treatment. Serology testing is done by numerous methods such as enzyme-linked immunosorbent assays (ELISAs), hemagglutinin-inhibition tests, flocculation tests, chemiluminescence immunoassays and neutralization tests

Serological Testing Market Dynamics

Drivers

• Increasing usage of chemiluminescence immunoassay

The market is witnessing a major shift away from the traditional ELISA method and moving towards the use of CLIA. Disease complications have surged the need to detect smaller target molecules, which leads to the emergence of CLIA. It is used in combination with a directly labelling antigen (antibody) and an indicator such as isoluminol, luminol, or an acridinium ester. The increasing sensitivity and accuracy of chemiluminescence immunoassay over enzyme-linked immunosorbent assay (ELISA) is anticipated to drive the market growth.

• Increase in Antibody Test

The antibody test contributes to the market growth. This dominance is due to the benefits of antibody tests and several advancements in the testing of the serological virus. The high demand for other tests such as viral load tests, genotype tests are going to increase in the forecast period because of the improvements and test accuracies and adoption by expert professionals.

Opportunities

• Growing Demand of ELISA

ELISA is of great demand and leading the market due to less turnaround time for testing, long self-life of regents, cheap and affordable reagents, a high number of infectious diseases screenings, high specificity, high sensitivity, and ELISA analyzers are inexpensive. Moreover, technological advancement, less complex steps required for performing, high precision screening, and many several key players are contributing to the growth of ELISA testing segment.

• Increasing Incidence of Tuberculosis

There has been increasing incidence of TB in the recent years that lead to the growth of the serological testing. India's TB incidence for the year 2021 is 210 per 100,000 population than the baseline year of 2015. The incidence was 256 per lakh of population in India and there has been an 18% deterioration. TB is the 13th leading cause of death worldwide and the second leading cause of infectious killer after COVID-19.

Restraints/Challenges

• High cost of Diagnostic Tests

There has been numerous tests that are hugely available for testing hepatitis diseases. But these tests are of increasing cost that is not afforded by numerous patients, mainly belonging to the lower economic groups. Thus, it hampers the market growth.

This serological testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the serological testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2021, Seimens and Hemogenomics made a clinical trial to do an extensive evaluation of the ADVIA Centaur XP chemiluminescence system.
• In 2019, Mylab Disocovery Solutions launched NATSpert, which is used to screen HIV, HBV, HCV in donated blood.

Global Serological Testing Market Scope

The serological testing market is segmented on the basis of test type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Primary Serological Tests
• Enzyme Linked Immunosorbent Assay (ELISA)
• Immunoflurescent Antibody Technique (IFAT)
• Radio Immunoassay (RIA)
• Secondary Serological Tests
• Agglutination Tests
• Complement Fixation Tests (CFT)
• Precipitation Tests
• Serum Neutralization Tests (SNT)
• Toxin-antitoxin Tests
• Tertiary Binding Tests

Application

• Rotavirus Infections
• Hepatitis
• HIV
• Endotoxins
• Therapeutic Drug Monitoring
• Other Infectious Diseases

End-user

• Hospital and Clinics
• Diagnostic Laboratories
• Blood Banks
• Diagnostic Laboratories
• Others

Serological Testing Regional Analysis/Insights

The serological testing market is analyzed and market size insights and trends are provided by test type, application and end-user as referenced above.

The countries covered in the serological testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the serological testing market due to the increasing incidence of infectious diseases, well-established health care infrastructure and rise in number of geriatric population in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the increase in awareness, and rise in per capita health care expenditure along with huge rate of infectious diseases in developing countries such as India and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The serological testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for serological testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the serological testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Global Serological Testing Market Share Analysis

The serological testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to serological testing market.

Some of the major players operating in the serological testing market are:

• Serological Research Institute (SERI) (U.K.)
• Chembio Diagnostics, Inc (U.S.)
• Cellex (U.S.)
• Randox Laboratories Ltd (U.K.)
•  Abbott (U.S.)
• Bio-Rad Laboratories Inc. (U.S.)
• BD (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Ortho Clinical Diagnostics (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Abcam Plc (U.K.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• ELITechGroup (France)
• Teleflex Incorporated (U.S.)
• Grifols, S.A. (U.S.)
• Global Scientific Company (India)
• Beckman Coulter, Inc. (U.S.)
• BIOMEDOMICS INC. (U.S.)
• Creative Diagnostics (U.S.)

SKU-57082